90 related articles for article (PubMed ID: 7166209)
1. Serum ferritin in pancreatic disease. An accurate test of malignancy?
Nitti D; Fabris C; Del Favero G; Farini R; Grassi F; Farini A; Baccaglini U; Pedrazzoli S; Piccoli A; Lise M; Naccarato R
Digestion; 1982; 25(4):258-62. PubMed ID: 7166209
[TBL] [Abstract][Full Text] [Related]
2. Limits of CEA and ferritin in the diagnosis of pancreatic cancer.
Plebani M; Fabris C; Basso D; Del Favero G; Angonese C; Leandro G; Di Mario F; Burlina A; Naccarato R
Int J Pancreatol; 1988; 3 Suppl 1():S113-7. PubMed ID: 3209864
[TBL] [Abstract][Full Text] [Related]
3. "Plasma"-type ribonuclease in pancreatic cancer diagnosis: a critical appraisal.
Fabris C; Farini R; del Favero G; Piccoli A; Naccarato R
Hepatogastroenterology; 1981 Dec; 28(6):316-8. PubMed ID: 7345012
[TBL] [Abstract][Full Text] [Related]
4. CEA and ferritin in chronic pancreatic disease: a comparative evaluation.
Fabris C; Farini R; Piccoli A; Del Favero G; Panucci A; Plebani M; Pedrazzoli S; Nitti D; Naccarato R
Hepatogastroenterology; 1985 Jun; 32(3):146-8. PubMed ID: 4018709
[TBL] [Abstract][Full Text] [Related]
5. Combined evaluation of serum ribonuclease and ferritin: any advantages in pancreatic cancer diagnosis?
Fabris C; Farini R; Del Favero G; Grassi F; Nitti D; Piccoli A; Brosolo P; Naccarato R
Oncology; 1984; 41(6):393-5. PubMed ID: 6504493
[TBL] [Abstract][Full Text] [Related]
6. Serum and correspondent tissue measurements of epidermal growth factor (EGF) and epidermal growth factor receptor (EGF-R). Clinical relevance in pancreatic cancer and chronic pancreatitis.
Birk D; Gansauge F; Gansauge S; Formentini A; Lucht A; Beger HG
Int J Pancreatol; 1999 Apr; 25(2):89-96. PubMed ID: 10360220
[TBL] [Abstract][Full Text] [Related]
7. Role of local and systemic factors in increasing serum glycoprotein markers of pancreatic cancer.
Fabris C; Basso D; Piccoli A; Meggiato T; Del Favero G; Fogar P; Panozzo MP; Faggian D; Vianello D; Plebani M
J Med; 1991; 22(3):145-56. PubMed ID: 1770322
[TBL] [Abstract][Full Text] [Related]
8. Serum prostate-specific antigen in pancreatic disease.
Pezzilli R; Bertaccini A; Billi P; Zanarini L; Miglio F; Martorana G
Ital J Gastroenterol Hepatol; 1999 Oct; 31(7):580-3. PubMed ID: 10604096
[TBL] [Abstract][Full Text] [Related]
9. Serum adenosine deaminase levels in pancreatic diseases.
Ibiş M; Köklü S; Yilmaz FM; Başar O; Yilmaz G; Yüksel O; Yildirim E; Oztürk ZA
Pancreatology; 2007; 7(5-6):526-30. PubMed ID: 17901713
[TBL] [Abstract][Full Text] [Related]
10. Serum soluble interleukin-2 receptor in pancreatic cancer and chronic pancreatitis.
Pezzilli R; Billi P; Beltrandi E; Mancini R; Casadei-Maldini M; Casadei R; Greco VM; Campione O; Miglioli M
Ital J Gastroenterol; 1994 Apr; 26(3):137-40. PubMed ID: 8061340
[TBL] [Abstract][Full Text] [Related]
11. Does serum CAR-3 play a role in pancreatic cancer diagnosis?
Basso D; Panozzo MP; Fabris C; Meggiato T; Faggian D; Fogar P; Scalon P; Del Favero G; Plebani M; Burlina A
Oncology; 1991; 48(1):22-5. PubMed ID: 1987495
[TBL] [Abstract][Full Text] [Related]
12. Hepatic changes and serum ferritin in pancreatic cancer and other gastrointestinal diseases: the role of cholestasis.
Basso D; Fabris C; Del Favero G; Meggiato T; Panozzo MP; Vianello D; Plebani M; Naccarato R
Ann Clin Biochem; 1991 Jan; 28 ( Pt 1)():34-8. PubMed ID: 2024931
[TBL] [Abstract][Full Text] [Related]
13. C reactive protein in pancreatic cancer and chronic pancreatitis.
Basso D; Fabris C; Meani A; Del Favero G; Vianello D; Angonese C; Meggiato T; Bellinvia S; Fogar P; Petrin P
Ann Clin Res; 1988; 20(6):414-6. PubMed ID: 3218913
[TBL] [Abstract][Full Text] [Related]
14. Soluble interleukin-2 receptor: a new marker in pancreatic adenocarcinoma?
Rabitti PG; Pacelli L; Uomo G; Laccetti M; Spada OA; Esposito G; Visconti M
Minerva Gastroenterol Dietol; 1994 Sep; 40(3):101-3. PubMed ID: 7948318
[TBL] [Abstract][Full Text] [Related]
15. Serum procarboxypeptidase A and carboxypeptidase A levels in pancreatic disease.
Kemik O; Kemik AS; Sumer A; Beğenik H; Dülger AC; Purisa S; Tuzun S
Hum Exp Toxicol; 2012 May; 31(5):447-51. PubMed ID: 21502183
[TBL] [Abstract][Full Text] [Related]
16. Abnormal serum pancreatic enzymes, but not pancreatitis, are associated with an increased risk of malignancy in patients with intraductal papillary mucinous neoplasms.
Roch AM; Parikh JA; Al-Haddad MA; DeWitt JM; Ceppa EP; House MG; Nakeeb A; Schmidt CM
Surgery; 2014 Oct; 156(4):923-9. PubMed ID: 25239347
[TBL] [Abstract][Full Text] [Related]
17. Utility of serum IgG, IgG4 and carbonic anhydrase II antibodies in distinguishing autoimmune pancreatitis from pancreatic cancer and chronic pancreatitis.
Talar-Wojnarowska R; Gąsiorowska A; Olakowski M; Dranka-Bojarowska D; Lampe P; Śmigielski J; Kujawiak M; Grzegorczyk J; Małecka-Panas E
Adv Med Sci; 2014 Sep; 59(2):288-92. PubMed ID: 25194335
[TBL] [Abstract][Full Text] [Related]
18. [Diagnostic value of serum angiopoietin-2 level in pancreatic cancer].
Wan RG; Chen DB; Lou YG; Wang MF; Zhang QH; Jin DX; Zhou SH
Zhonghua Zhong Liu Za Zhi; 2011 Jan; 33(1):47-9. PubMed ID: 21575464
[TBL] [Abstract][Full Text] [Related]
19. [Serum carcinoembryonic antigen (CEA) and carbohydrate antigen (CA 19-9) values in patients with pancreatic cancer or pancreatitis].
Changchine CS; Yung CY; Tzen KY
Changgeng Yi Xue Za Zhi; 1991 Mar; 14(1):32-8. PubMed ID: 2039968
[TBL] [Abstract][Full Text] [Related]
20. Immunoglobulin G4, autoimmune pancreatitis and pancreatic cancer.
Bojková M; Dítě P; Dvořáčková J; Novotný I; Floreánová K; Kianička B; Uvírová M; Martínek A
Dig Dis; 2015; 33(1):86-90. PubMed ID: 25531501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
